Main Session
Sep
27
PQA 01 - PQA 01: Gastrointestinal Cancer and Central Nervous System
2214 - A Phase II Study of Fruquintinib Combined with Tislelizumab and Sequential Radiotherapy for Recurrent or Oligoprogressive Esophageal Squamous Cell Carcinoma
Presenter(s)
Wenbin Shen, - The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei